Cholecystitis, Acute, Drain Abscess, Elderly Infection
Conditions
Brief summary
In a setting of acute cholecystitis (AC) one of the treatment option is percutaneous transhepatic cholangiography (PTHC) drainage. The goal of current study is to evaluate some radiology aspects and correlate with clinical patient outcomes in patients with acute cholecystitis severity grade III (presented as acute cholecystitis with organ dysfunction).
Interventions
PROCEDUREPercutaneous cholecystostomy
Placement of drainage catheter into gallbladder lumen in order to evacuate inflamed content.
Sponsors
University of Split, School of Medicine
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Inclusion criteria
* clinical markers of acute cholecystitis * diagnosis confirmed with some imaging technique: computed tomography (CT), ultrasound (US).
Exclusion criteria
* clinical diagnosis was not confirmed with imaging.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| C-reactive protein (CRP) | Up to 8 weeks. | C-reactive protein (CRP) is a protein found in blood plasma, whose levels rise in response to inflammation. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Drainage duration (expressed in days) | Up to 16 weeks. | The drain which is placed in gallbladder during Percutaneous transhepatic cholangiography (PTHC) remains there until resolving clinical parameters of acute cholecystitis. |
| White blood cells (WBCs) count | Up to 8 weeks. | White blood cells (WBCs) are the cells of the immune system. During inflammation White blood cell level rise. |
Countries
Croatia
Outcome results
None listed